Eagle Medical Systems Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 3.00 Cr
as on 16-11-2024
- Company Age 27 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 28.04 Cr
as on 16-11-2024
- Satisfied Charges ₹ 3.35 Cr
as on 16-11-2024
- Revenue -42.84%
(FY 2023)
- Profit 11.96%
(FY 2023)
- Ebitda 13.82%
(FY 2023)
- Net Worth 36.44%
(FY 2023)
- Total Assets -6.50%
(FY 2023)
About Eagle Medical Systems
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹28.04 Cr. The company has closed loans amounting to ₹3.35 Cr, as per Ministry of Corporate Affairs (MCA) records.
Karan Bhasin and Ramesh Bhasin serve as directors at the Company.
- CIN/LLPIN
U29297DL1997PTC090018
- Company No.
090018
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Oct 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Eagle Medical Systems?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Karan Bhasin  | Director | 30-Mar-2015 | Current |
| Ramesh Bhasin | Director | 06-Oct-1997 | Current |
Financial Performance of Eagle Medical Systems.
Eagle Medical Systems Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 42.84% decrease. The company also saw a substantial improvement in profitability, with a 11.96% increase in profit. The company's net worth Soared by an impressive increase of 36.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eagle Medical Systems?
In 2023, Eagle Medical Systems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 29 Aug 2022 | ₹1.80 M | Open |
Indian Overseas Bank Creation Date: 08 Jul 2021 | ₹3.50 M | Open |
Indian Overseas Bank Creation Date: 18 Feb 2021 | ₹1.09 M | Open |
How Many Employees Work at Eagle Medical Systems?
Unlock and access historical data on people associated with Eagle Medical Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eagle Medical Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eagle Medical Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
